Possible osteosarcopenia went with lower intrinsic capacity and poorer cognition at six months

Design

Longitudinal cohort from a national household survey

Population

2,291 older adults in Singapore

Primary outcome

Intrinsic capacity at baseline and cognitive function at 6 months

Effect

Possible osteosarcopenia in 50.3%; associated with lower intrinsic capacity and poorer cognition at 6 months

This longitudinal study recruited 2,291 older adults through a national household survey in Singapore. Possible osteosarcopenia was defined as possible osteoporosis together with possible sarcopenia. The researchers related it to intrinsic capacity at baseline and to cognitive function six months later.

Possible osteosarcopenia was present in 50.3% of participants. It was associated with lower intrinsic capacity, including cognition, at baseline, and with poorer cognitive function at six months, particularly in people who already had lost cognitive capacity. The difference was driven by delayed recall and orientation. Higher education, social networks, resilience and quality of life were linked to better intrinsic capacity and cognition.

The definition used screening-level criteria for possible disease rather than confirmed densitometry, and six months is short. This is an association from observational data, and the direction of any relation is uncertain: early cognitive decline may reduce activity and worsen muscle and bone.

• Consider screening for sarcopenia and low bone density together in older adults, since half had both possible conditions.
• Check delayed recall and orientation when function declines.
• Support social contact and resilience, which were linked to better capacity.
• Offer strength and balance training and attention to nutrition.

Why it matters

It links musculoskeletal and cognitive decline in the same patients, which often get assessed separately.

Don't overread it

Observational associations over six months with screening-level definitions cannot establish cause or show that treating osteosarcopenia protects cognition.

The statistics, in plain English

A prevalence of 50.3% for 'possible' osteosarcopenia reflects broad screening criteria and will overstate confirmed disease. The six-month follow-up cannot show whether muscle and bone loss cause cognitive decline or just share causes with it.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.